Bioprospecting of inhibitors of EPEC virulence from metabolites of marine actinobacteria from the Arctic Sea
A considerable number of antibacterial agents are derived from bacterial metabolites. Similarly, numerous known compounds that impede bacterial virulence stem from bacterial metabolites. Enteropathogenic Escherichia coli (EPEC) is a notable human pathogen causing intestinal infections, particularly...
Main Authors: | , , , , |
---|---|
Other Authors: | , , , , , |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
Frontiers Media
2024
|
Subjects: | |
Online Access: | http://hdl.handle.net/10138/586381 |
_version_ | 1821788918870179840 |
---|---|
author | Pylkkö, Tuomas Schneider, Yannik Karl-Heinz Rämä, Teppo Andersen, Jeanette Hammer Tammela, Päivi |
author2 | Division of Pharmaceutical Biosciences Bioactivity Screening Group Drug Research Program Faculty of Pharmacy University of Helsinki Divisions of Faculty of Pharmacy |
author_facet | Pylkkö, Tuomas Schneider, Yannik Karl-Heinz Rämä, Teppo Andersen, Jeanette Hammer Tammela, Päivi |
author_sort | Pylkkö, Tuomas |
collection | HELDA – University of Helsinki Open Repository |
description | A considerable number of antibacterial agents are derived from bacterial metabolites. Similarly, numerous known compounds that impede bacterial virulence stem from bacterial metabolites. Enteropathogenic Escherichia coli (EPEC) is a notable human pathogen causing intestinal infections, particularly affecting infant mortality in developing regions. These infections are characterized by microvilli effacement and intestinal epithelial lesions linked with aberrant actin polymerization. This study aimed to identify potential antivirulence compounds for EPEC infections among bacterial metabolites harvested from marine actinobacteria (Kocuria sp. and Rhodococcus spp.) from the Arctic Sea by the application of virulence-based screening assays. Moreover, we demonstrate the suitability of these antivirulence assays to screen actinobacteria extract fractions for the bioassay-guided identification of metabolites. We discovered a compound in the fifth fraction of a Kocuria strain that interferes with EPEC-induced actin polymerization without affecting growth. Furthermore, a growth-inhibiting compound was identified in the fifth fraction of a Rhodococcus strain. Our findings include the bioassay-guided identification, HPLC-MS-based dereplication, and isolation of a large phospholipid and a likely antimicrobial peptide, demonstrating the usefulness of this approach in screening for compounds capable of inhibiting EPEC virulence. Peer reviewed |
format | Article in Journal/Newspaper |
genre | Arctic Arctic |
genre_facet | Arctic Arctic |
geographic | Arctic |
geographic_facet | Arctic |
id | ftunivhelsihelda:oai:helda.helsinki.fi:10138/586381 |
institution | Open Polar |
language | English |
op_collection_id | ftunivhelsihelda |
op_relation | 10.3389/fmicb.2024.1432475 Finlands Akademi 358776 TP acknowledges mobility funding from EU-OPENSCREEN ERIC and NordForsk for the Nordic University Hub project #85352 (Nordic POP, Patient Oriented Products), which allowed onsite visit to MARBIO/UiT-The Arctic University of Norway. The work on compound identification and isolation was supported by UiT The Arctic University of Norway and Tromsø Forskningstiftelse (grant 2520855, Center for New Antibacterial Strategies). RIS: urn:F54268D538A64EBDDA73153B7A4CB0B5 http://hdl.handle.net/10138/586381 85203985941 001310373400001 |
op_rights | cc_by info:eu-repo/semantics/openAccess openAccess |
publishDate | 2024 |
publisher | Frontiers Media |
record_format | openpolar |
spelling | ftunivhelsihelda:oai:helda.helsinki.fi:10138/586381 2025-01-16T19:52:52+00:00 Bioprospecting of inhibitors of EPEC virulence from metabolites of marine actinobacteria from the Arctic Sea Pylkkö, Tuomas Schneider, Yannik Karl-Heinz Rämä, Teppo Andersen, Jeanette Hammer Tammela, Päivi Division of Pharmaceutical Biosciences Bioactivity Screening Group Drug Research Program Faculty of Pharmacy University of Helsinki Divisions of Faculty of Pharmacy 2024-10-01T09:24:03Z 12 application/pdf http://hdl.handle.net/10138/586381 eng eng Frontiers Media 10.3389/fmicb.2024.1432475 Finlands Akademi 358776 TP acknowledges mobility funding from EU-OPENSCREEN ERIC and NordForsk for the Nordic University Hub project #85352 (Nordic POP, Patient Oriented Products), which allowed onsite visit to MARBIO/UiT-The Arctic University of Norway. The work on compound identification and isolation was supported by UiT The Arctic University of Norway and Tromsø Forskningstiftelse (grant 2520855, Center for New Antibacterial Strategies). RIS: urn:F54268D538A64EBDDA73153B7A4CB0B5 http://hdl.handle.net/10138/586381 85203985941 001310373400001 cc_by info:eu-repo/semantics/openAccess openAccess 11832 Microbiology and virology Article publishedVersion 2024 ftunivhelsihelda 2024-10-10T00:14:43Z A considerable number of antibacterial agents are derived from bacterial metabolites. Similarly, numerous known compounds that impede bacterial virulence stem from bacterial metabolites. Enteropathogenic Escherichia coli (EPEC) is a notable human pathogen causing intestinal infections, particularly affecting infant mortality in developing regions. These infections are characterized by microvilli effacement and intestinal epithelial lesions linked with aberrant actin polymerization. This study aimed to identify potential antivirulence compounds for EPEC infections among bacterial metabolites harvested from marine actinobacteria (Kocuria sp. and Rhodococcus spp.) from the Arctic Sea by the application of virulence-based screening assays. Moreover, we demonstrate the suitability of these antivirulence assays to screen actinobacteria extract fractions for the bioassay-guided identification of metabolites. We discovered a compound in the fifth fraction of a Kocuria strain that interferes with EPEC-induced actin polymerization without affecting growth. Furthermore, a growth-inhibiting compound was identified in the fifth fraction of a Rhodococcus strain. Our findings include the bioassay-guided identification, HPLC-MS-based dereplication, and isolation of a large phospholipid and a likely antimicrobial peptide, demonstrating the usefulness of this approach in screening for compounds capable of inhibiting EPEC virulence. Peer reviewed Article in Journal/Newspaper Arctic Arctic HELDA – University of Helsinki Open Repository Arctic |
spellingShingle | 11832 Microbiology and virology Pylkkö, Tuomas Schneider, Yannik Karl-Heinz Rämä, Teppo Andersen, Jeanette Hammer Tammela, Päivi Bioprospecting of inhibitors of EPEC virulence from metabolites of marine actinobacteria from the Arctic Sea |
title | Bioprospecting of inhibitors of EPEC virulence from metabolites of marine actinobacteria from the Arctic Sea |
title_full | Bioprospecting of inhibitors of EPEC virulence from metabolites of marine actinobacteria from the Arctic Sea |
title_fullStr | Bioprospecting of inhibitors of EPEC virulence from metabolites of marine actinobacteria from the Arctic Sea |
title_full_unstemmed | Bioprospecting of inhibitors of EPEC virulence from metabolites of marine actinobacteria from the Arctic Sea |
title_short | Bioprospecting of inhibitors of EPEC virulence from metabolites of marine actinobacteria from the Arctic Sea |
title_sort | bioprospecting of inhibitors of epec virulence from metabolites of marine actinobacteria from the arctic sea |
topic | 11832 Microbiology and virology |
topic_facet | 11832 Microbiology and virology |
url | http://hdl.handle.net/10138/586381 |